Answers are grounded in this paper and cite their sources.
Baseline FDG-PET and episodic memory predict conversion to AD, whereas p-tau(181p)/Abeta(1-42) and, marginally, FDG-PET predict longitudinal cognitive decline. Complementary information provided by these biomarkers may aid in future selection of patients for clinical trials or identification of patients likely to benefit from a therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Landau et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: